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In this issue, Lande et al.1 in Philadelphia report unexpectedly high rates of lung cancer among individuals with prior or concurrent Mycobacterium avium complex (MAC) lung 
infection. Two striking aspects of this comorbidity were noted: 1) cancer was considerably 
more prominent among nonsmoking women with MAC than among nonsmoking women 
without MAC, and 2 there were unexpectedly high rates of squamous cell carcinoma in the 
peripheral airways of these MAC-infected women.
The possible relationship of lung cancer to another mycobacterial lung infection, 
M. tuberculosis, is a good launching point in considering the potential role of MAC in 
oncogenesis. In the prechemotherapy era of tuberculosis (TB) (before 1950), clinicians 
widely held that because TB resulted in high mortality in early adulthood, lung cancer 
(which has always been most common in those > 50 years of age) would be uncommon 
among those with TB.2 But, with the advent of curative therapy for TB, lung cancers began 
appearing among TB survivors. Among the hypotheses entertained for this relationship was 
transition from the inflammatory dysplasia of the infection to malignant neoplasia.3 There 
was also a briefly held theory that isoniazid, the most significant drug of the early chemo-
therapy era, was oncogenic.
Ultimately, the notion of infection-engendered dysplasia/metaplasia transforming 
to cancer became the widely accepted paradigm and there are now many other examples 
of cancers being associated with prior infection.4 Thus, the supposition that pulmonary 
MAC may serve as a predisposition for lung cancer is an appealing one. MAC, in con-
trast to untreated TB, is unlikely to cause rapidly progressive disease and premature death. 
Rather, the natural history of MAC, particularly in women who commonly manifest indo-
lent,  airway-centered disease with bronchiectasis, is a chronic disease extending over 
decades.5 This pattern is compatible anatomically with the observation among patients in 
the Philadelphia series, who presented predominantly with peripheral airway squamous 
carcinomas. End of story, or is it?
One of the striking curiosities of MAC lung disease over the past three decades is 
increasing prevalence rates among women.6 Early series of pulmonary MAC in the United 
States, Europe, and Japan featured men who typically suffered tobacco-related chronic 
obstructive pulmonary disease or work-related pneumoconiosis.5 These men most com-
monly had upper-lobe, cavitary destructive disease very similar to classic TB.
However, in 1989, a series of patients with pulmonary MAC was reported from these 
same hospitals (Lankenau and Thomas Jefferson) in Philadelphia, the authors including one 
of the contributors to the current article, Donald Peterson.7 In addition to the typical male/
chronic obstructive pulmonary disease form of disease and disseminated MAC in patients 
with AIDS, they described 21 patients without predisposing conditions; of the latter group, 
17 were women in whom progressive nodular opacities predominated.
Over subsequent decades, multiple reports have documented that the preponderance 
of pulmonary MAC disease was being seen among women, the majority with bronchiectasis 
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(the recognition of bronchiectasis widely reflects increased 
use of computed tomographic scanning, the optimal tool for 
identifying airway morphology).6,8 Striking elements of the 
epidemiology include a female preponderance that increases 
with age, a remarkably high percentage of cases among white 
women, and a paucity of cases in African Americans. Looking 
at the female MAC patients, a variety of morphological 
features were described by various observers: narrowing of the 
anterior-posterior chest dimensions, occasional frank pectus 
excavatum, taller-than-average stature, and slenderness/low 
body mass index.7,9,10
MAC is widely distributed in the environment, particu-
larly in water. It has been postulated that exposure to MAC 
may be related to potable home water systems.11 However, 
this model should expose both sexes and all morphotypes 
in roughly equal degrees. Hence, it might be postulated that 
women with this morphotype may have some inherent sus-
ceptibility to MAC infection. Do they also have an inherent 
susceptibility to lung cancer?
A simple construct would be that, because of this 
vulnerability, women develop chronic MAC infection of 
their airways leading to inflammation, dysplasia and—ulti-
mately—neoplasm. Unfortunately, the study by Lande et al.1 
cannot address this construct as it is impossible to determine 
which came first, the chicken or the egg, given the retrospec-
tive design. So we are left with the question, did the chronic 
inflammatory environment created by MAC lead to the devel-
opment of lung cancer or did lung cancer allow the establish-
ment of infection with MAC? It is likely that both constructs 
are playing a role in this association but determining which 
is the more important will be challenging. Hopefully, further 
research will be able to determine whether the altered biology, 
which allows invasive MAC infection, may also be permissive 
of preneoplastic changes that eventuate in the lung cancers 
that are the focus of the series from Philadelphia.
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